Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-26 @ 5:35 AM
Study NCT ID:
NCT04143594
Status:
COMPLETED
Last Update Posted:
2024-10-02
First Post:
2019-10-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-22
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-19
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-28
First Submit QC Date:
None
Study First Post Date:
2019-10-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-29
Results First Submit QC Date:
None
Results First Post Date:
2022-12-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-09
Last Update Post Date:
2024-10-02
Last Update Post Date Type:
ACTUAL